Drug-Eluting Balloons: Are They the Magic Bullet?

Lammer J Bosiers M Zeller T First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011;54:394–401

Bosiers M Scheinert D Peeters P Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390–398

Dake MD Ansel GM Jaff MR Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495–504

Duda SH Bosiers M Lammer J Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701–710

Rastan A Tepe G Krankenberg H Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011;32:2274–2281

Tepe G Zeller T Albrecht T Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689–699

Werner M Schmidt A Freyer M Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up. J Endovasc Ther. 2012;19:12–19

Zeller T Schmitmeier S Tepe G Drug-coated balloons in the lower limb. J Cardiovasc Surg (Torino). 2011;52:235–243

Schmidt A Piorkowski M Werner M First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58:1105–1109

Werk M Langner S Reinkensmeier B Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358–1365

Scheinert D. Six-month results of the LEVANT 1 trial. Presented at Transcatheter Cardiovascular Therapeutics (TCT) Conference held in Washington DC, USA, September 23, 2010. Available at: http://www.tctmd.com/show.aspx?id=102034 . Last accessed July 10, 2012

Scheinert D. The Achilles study–A prospective, randomized, multicenter comparison of balloon angioplasty and the CYPHER SELECT plus coronary and infrapopliteal stent in the treatment of subjects with ischemic infrapopliteal arterial disease. Presented at LINC 2011 held in Leipzig, Germany, January 19–22, 2011. Available at: http://www.leipzig-interventional-course.com/index.php?option=com_docman&task=doc_download&gid=799 . Last accessed July 10, 2012

Werk M Albrecht T Meyer DR The PACIFIER trial: a randomized multicenter trial evaluating prevention of restenosis with paclitaxel-coated PTA balloon catheters in stenosis or occlusion of femoropopliteal arteries. Presented at LINC 2012 held in Leipzig, Germany, January 25–28, 2012. Available at: http://www.leipzig-interventional-course.com/index.php?option=com_docman&task=doc_download&gid=1053 . Last accessed July 10, 2012

Stone GW Rizvi A Sudhir K Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Ever-olimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol. 2011;58:19–25

Feiring AJ Krahn M Nelson L Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010;55:1580–1589.

Fanelli F Cannavale A Boatta E Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012;19:571–580